e-learning
resources
Berlin 2008
Monday, 06.10.2008
Clinical epidemiology of tuberculosis III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran
M. Shamaei, P. Tabarsi, M. Marjani, E. Chitsaz, D. Mansouri, M. R. Masjedi, P. Baghaei (Tehran, Islamic Republic Of Iran)
Source:
Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Session:
Clinical epidemiology of tuberculosis III
Session type:
Thematic Poster Session
Number:
2492
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Shamaei, P. Tabarsi, M. Marjani, E. Chitsaz, D. Mansouri, M. R. Masjedi, P. Baghaei (Tehran, Islamic Republic Of Iran). First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran. Eur Respir J 2008; 32: Suppl. 52, 2492
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Second-line tuberculosis drug resistance study from a referal center of Turkey
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II
Year: 2008
Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Spreading of resistance to group A anti-tuberculosis drugs among TB patients in Astana city
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Resistance to second-line antituberculous drugs of
Mtb
strains in TB institute clinic
Source: Eur Respir J 2007; 30: Suppl. 51, 442s
Year: 2007
Antituberculosis drug resistance in a secondary care hospital in Turkey
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007
The association between HIV and antituberculosis drug resistance
Source: Eur Respir J 2008; 32: 718-725
Year: 2008
A Cuban successful history on antituberculosis treatment and drug resistance surveillance
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
MDR-TB treatment in prison setting
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007
Treatment outcomes of new cases of polyresistant pulmonary TB with second line anti-TB drugs in DOTS-Plus regimen
Source: Eur Respir J 2002; 20: Suppl. 38, 359s
Year: 2002
Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002
Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
MDR-TB and XDR-TB: drug resistance and treatment outcomes
Source: Eur Respir J 2009; 34: 778
Year: 2009
Resistance to second-line anti-tuberculosis drugs: new drug resistant TB treatment problem
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007
Pattern of drug resistance in TB patients treated at DR TB unit in tertiary care public sector hospital in Karachi Pakistan
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept